ADORA2A and neoplasm: The use of Adora2afloxflox;Ncr1iCre mice (in which A2AR is selectively deleted in NK cells) established that A2AR directly inhibits NK cell anti-tumor activity against transplantable SM1WT1 BRAF-mutant melanoma [173].